M.S. is a disease of the brain and spinal cord that affects almost a million people in the United States. About 1,200 here in ...

Columnist Ben Hofmeister compares living with MS to having a high-maintenance car; both need special treatment, he writes.

Myrobalan to receive over $850,000 in funding to advance the development of its GPR17 antagonist for progressive MS from the ...

“Broadening access to cladribine means thousands more patients will benefit from managing their treatment at home rather than regularly attending hospital appointments – as well giving women with MS ...

Anti-neurofilament L antibodies play a crucial role in detecting and monitoring neurodegenerative diseases, including Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), and multiple sclerosis ...

An Angleton woman has decided to fight back against multiple sclerosis, leading the charge for other survivors and bringing ...

An Angleton woman has decided to fight back against multiple sclerosis, leading the charge for other survivors and bringing ...

March is MS Awareness Month, and this week we’re spotlighting the nearly one million people in the U.S. living with multiple sclerosis. Julie Hirsch from the National MS Society of Michigan joins us ...

Thousands of NHS patients in England with multiple sclerosis (MS) are set to benefit from a life-changing ‘take at home’ tablet, as the NHS becomes the first healthcare system in Europe to roll it out ...

Among patients with multiple sclerosis, depression or anxiety are associated with being on Medicaid, clinical relapse, and DMT delay.

In this interview, Dr Tiffany Braley discusses the results of her latest study and best practices for personalized patient ...

Reports of anaphylaxis associated with the use of glatiramer acetate have prompted the Food and Drug Administration (FDA) to add a Boxed Warning to the prescribing information.